Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Radhika Rajiv Mahajan"'
Publikováno v:
Discover Nano, Vol 19, Iss 1, Pp 1-20 (2024)
Abstract In this research work, optimized nebivolol-loaded lecithin-chitosan hybrid nanoparticles (NEB-LCNPs) were prepared using sequential screening and optimization designs. The design of experiments software (DoE) was used to obtain a robust form
Externí odkaz:
https://doaj.org/article/84168f03940f4e23841f4b6d441f4e77
Autor:
Pradeep Singh Rawat, Punna Rao Ravi, Mohammed Shareef Khan, Radhika Rajiv Mahajan, Łukasz Szeleszczuk
Publikováno v:
Nanomaterials, Vol 14, Iss 16, p 1347 (2024)
Nebivolol hydrochloride (NEB), a 3rd-generation beta-blocker, was recently explored in managing open-angle glaucoma due to its mechanism of action involving nitric oxide release for the vasodilation. To overcome the issue of low ocular bioavailabilit
Externí odkaz:
https://doaj.org/article/e2223d00dd884daebb8cd25c75866be0
Autor:
Radhika Rajiv Mahajan, Punna Rao Ravi, Riya Kamlesh Marathe, Ajay Gorakh Dongare, Apoorva Vinayak Prabhu, Łukasz Szeleszczuk
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 1087 (2024)
Neratinib maleate (NM), a tyrosine kinase inhibitor, is used in the treatment of breast cancer. NM is orally administered at a high dose of 290 mg due to its low solubility and poor dissolution rate at pH > 3, as well as gut-wall metabolism limiting
Externí odkaz:
https://doaj.org/article/8cc7983cb3f646dba00a086a7fcf317e